Chronic obstructive pulmonary disease (COPD)
615 results
201 - 300
Beta-blockers associated with improved morbidity/mortality in COPD patients- USPSTF: D recommendation against screening for COPD in asymptomatic adults
- Long-acting bronchodilators similarly safe in COPD patients
- Risk of serious pneumonia in COPD patients using inhaled corticosteroids
Pneumococcal vaccines for preventing pneumonia in chronic obstructive pulmonary disease- Self‐management interventions including action plans for exacerbations versus usual care in patients with chronic obstructive pulmonary disease
- Telehealthcare for chronic obstructive pulmonary disease
- Hospital at home for acute exacerbations of chronic obstructive pulmonary disease
- O2 not helpful in overall QOL in COPD with exertional hypoxia
- Mepolizumab provides a small reduction in the exacerbations of moderate to severe eosinophilic COPD
- Long-term erythromycin decreases COPD exacerbations
- Inhaled corticosteroids increase pneumonia risk in stable COPD
- No change in duration of mechanical ventilation with acetazolamide for COPD patients with metabolic alkalosis
Theophylline for exacerbations of COPD - Nocturnal positive pressure ventilation for COPD
- Prevalence of pulmonary embolism is 5.9% in patients with COPD who are hospitalized with acute respiratory symptoms
- Psychological therapies for the treatment of anxiety disorders in chronic obstructive pulmonary disease: Cochrane systematic review
- Low-dose theophylline is minimally helpful, if at all, in preventing COPD exacerbations
- Three-month spirometry does not improve health outcomes for patients with asthma and/or COPD
- Tiotropium mist associated with mortality in COPD treatment
- 5-day steroid treatment effective for acute COPD exacerbation
- Tiotropium versus ipratropium bromide for chronic obstructive pulmonary disease
- Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease
- Tiotropium versus placebo for chronic obstructive pulmonary disease
- Azithromycin of questionable benefit given daily for COPD
- Psychological therapies for the treatment of depression in chronic obstructive pulmonary disease
- In high-risk patients with chronic obstructive pulmonary disease, dupilumab slightly reduces moderate exacerbation (BOREAS)
- LABA+LAMA+ICS associated with greater decline in all-cause mortality than LABA+LAMA in patients with severe COPD (IMPACT)
- American Thoracic Society home oxygen guideline for patients with COPD or interstitial lung disease
- Long‐acting beta2‐agonist in addition to tiotropium versus either tiotropium or long‐acting beta2‐agonist alone for chronic obstructive pulmonary disease
- Mucolytic agents versus placebo for chronic bronchitis or chronic obstructive pulmonary disease
- Population-based case-finding intervention to identify undiagnosed COPD and asthma has minimal benefits
- Mepolizumab provides only a small reduction in moderate exacerbations when added to triple inhaler therapy for eosinophilic COPD (MATINEE)
- Fluticasone + salmeterol may reduce mortality but also increase pneumonia in COPD
- Inhaled steroids for COPD associated with increased risk of pneumonia
- Low-dose oral = high-dose IV steroids for initial treatment of acute COPD exacerbation
- Self-management training, routine monitoring not effective for COPD
- Inhaled corticosteroids versus placebo for stable chronic obstructive pulmonary disease
- Cardioselective beta-blockers for chronic obstructive pulmonary disease
- Optimal intensity and type of leg exercise training for people with chronic obstructive pulmonary disease
- Antibiotic and corticosteroid treatment effective for acute exacerbations of COPD
- One year of once-daily doxycycline does not reduce exacerbation frequency in adults with moderate to severe COPD
- Guidelines for COPD (ACP)
- Inhaled anticholinergics associated with increased risk of CVD in COPD
- Helium-oxygen improves exercise tolerance in pts with COPD
- Salmeterol + fluticasone better than tiotropium in COPD (INSPIRE)
- Better outcomes with noninvasive ventilation for hospitalized COPD patients
- Combination inhaled steroid and long‐acting beta2‐agonist in addition to tiotropium versus tiotropium or combination alone for chronic obstructive pulmonary disease
- Dyspnoea
- Procalcitonin test can reduce antibiotic use in COPD
- Steroid inhalers increase fracture risk in COPD
- Self‐management interventions for people with chronic obstructive pulmonary disease
- Pharmacological interventions for the treatment of anxiety disorders in chronic obstructive pulmonary disease: Cochrane systematic review
- Antibiotics for exacerbations of chronic obstructive pulmonary disease
- Action plans with brief patient education for exacerbations in chronic obstructive pulmonary disease
- Home care by outreach nursing for chronic obstructive pulmonary disease
- C-reactive protein guidance safely reduces antibiotic use in patients with acute exacerbation of COPD (NNT = 5)
- Early outpatient follow-up linked with fewer readmissions for COPD patients
- Amox-clavulanate during COPD exacerbations decreases Sx and delays subsequent exacerbations
- Ambulatory oxygen for improving exercise capacity in patients with COPD
- For mild to severe COPD exacerbations, antibiotics and steroids remain the mainstay of treatment
- Hippocratic nails - Image
- Immunostimulants versus placebo for preventing exacerbations in adults with chronic bronchitis or chronic obstructive pulmonary disease
- Domiciliary oxygen for chronic obstructive pulmonary disease
- Methylxanthines for exacerbations of chronic obstructive pulmonary disease
- Acute bronchitis
- Prolonged cough in adults
- Haemophilus influenzae oral vaccination for preventing acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease
- COPD -- combo therapy improves symptoms but doesn't decrease exacerbations
- Tiotropium via Soft Mist Inhaler increases all-cause mortality in COPD
- Heliox for treatment of exacerbations of chronic obstructive pulmonary disease
- Exercise stress test
- Fluticasone plus vilanterol an option for COPD
- Oxygen for breathlessness in patients with chronic obstructive pulmonary disease who do not qualify for home oxygen therapy
- Once‐daily long‐acting beta₂‐agonists/inhaled corticosteroids combined inhalers versus inhaled long‐acting muscarinic antagonists for people with chronic obstructive pulmonary disease
- Smoking cessation for people with chronic obstructive pulmonary disease
- Non‐pharmacological interventions for the prevention of hospitalisations in stable chronic obstructive pulmonary disease: component network meta‐analysis
- Hospital at home for acute exacerbations of chronic obstructive pulmonary disease
- Singing for adults with chronic obstructive pulmonary disease
- Influenza vaccine for patients with chronic obstructive pulmonary disease
- C-reactive protein helps reduce antibiotic prescribing for COPD exacerbations
- Reduced readmissions with home NIV plus oxygen for COPD exacerbation with persistent hypercapnia
- Nocturnal oxygen for COPD patients who do not qualify for daytime oxygen is unlikely to be helpful (INOX)
- Pneumonia
- Beclometasone for chronic obstructive pulmonary disease: Cochrane systematic review
- Water‐based exercise training for chronic obstructive pulmonary disease
- Aclidinium bromide for stable chronic obstructive pulmonary disease